Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
HBIGS Heidelberg Biosciences International Graduate School | Heidelberg, Baden W rttemberg | Germany | about 16 hours ago
, stem cell homeostasis, proliferation and differentiation and is frequently dysregulated in human cancer. In this project you will develop and apply advanced CRISPR genome engineering methods
-
disease, particularly in the context of therapy resistance in colorectal cancer. We are looking for an ambitious cancer biologist to work in Dr Li laboratory who can integrate functional CRISPR screens with
-
of São Paulo (UNIFESP), in Brazil, aims to investigate how CRISPR-Cas9-mediated genetic modification of Invariant Natural Killer T (iNKT) cells can modulate their antitumor activity and therapeutic
-
our publications here . Our team is at the forefront of bringing autologous cell replacement therapies with CRISPR-edited muscle stem cells towards the clinic (https://www.mdc-berlin.de/news/news/deep
-
of Medicine (Houston). https://www.bcm.edu/research/faculty-labs/chunmei-wang-lab The Wang lab is interested in transcriptional regulations in hypothalamic neurons and their roles in energy homeostasis, and
-
environment. n line with our and Uni Basel values (https://www.unibas.ch/en/Research/Values-Ethics/Diversity.html ), we are committed to sustain and promote an inclusive culture, ensure equal opportunities and
-
environment. In line with our and Uni Basel values ( https://www.unibas.ch/en/Research/Values-Ethics/Diversity-and-Inclusion.html ), we are committed to sustain and promote an inclusive culture, ensure equal
-
sarcomas, where chromosomal translocations generate fusion oncoproteins that serve as drivers of the disease. By combining a toolbox consisting of CRISPR/Cas9, RNAi technology, cellular barcoding, and mouse